A shotgun metagenomic analysis of the fecal microbiome in humans infected with Giardia duodenalis
The mechanisms underlying the clinical outcome disparity during human infection with Giardia duodenalis are still unclear. In recent years, evidence has pointed to the roles of host factors as well as parasite's genetic heterogeneity as major contributing factors in the development of symptomat...
Saved in:
| Published in | Parasites & vectors Vol. 16; no. 1; p. 239 |
|---|---|
| Main Authors | , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
England
BioMed Central Ltd
18.07.2023
BioMed Central BMC |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1756-3305 1756-3305 |
| DOI | 10.1186/s13071-023-05821-1 |
Cover
Loading…
| Abstract | The mechanisms underlying the clinical outcome disparity during human infection with Giardia duodenalis are still unclear. In recent years, evidence has pointed to the roles of host factors as well as parasite's genetic heterogeneity as major contributing factors in the development of symptomatic human giardiasis. However, it remains contested as to how only a small fraction of individuals infected with G. duodenalis develop clinical gastrointestinal manifestations, whereas the majority of infected individuals remain asymptomatic. Here, we demonstrate that diversity in the fecal microbiome correlates with the clinical outcome of human giardiasis.
The genetic heterogeneity of G. duodenalis clinical isolates from human subjects with asymptomatic and symptomatic giardiasis was determined using a multilocus analysis approach. We also assessed the genetic proximity of G. duodenalis isolates by constructing phylogenetic trees using the maximum likelihood. Total genomic DNA (gDNA) from fecal specimens was utilized to construct DNA libraries, followed by performing paired-end sequencing using the HiSeq X platform. The Kraken2-generated, filtered FASTQ files were assigned to microbial metabolic pathways and functions using HUMAnN 3.04 and the UniRef90 diamond annotated full reference database (version 201901b). Results from HUMAnN for each sample were evaluated for differences among the biological groups using the Kruskal-Wallis non-parametric test with a post hoc Dunn test.
We found that a total of 8/11 (72.73%) human subjects were infected with assemblage A (sub-assemblage AII) of G. duodenalis, whereas 3/11 (27.27%) human subjects in the current study were infected with assemblage B of the parasite. We also found that the parasite's genetic diversity was not associated with the clinical outcome of the infection. Further phylogenetic analysis based on the tpi and gdh loci indicated that those clinical isolates belonging to assemblage A of G. duodenalis subjects clustered compactly together in a monophyletic clade despite being isolated from human subjects with asymptomatic and symptomatic human giardiasis. Using a metagenomic shotgun sequencing approach, we observed that infected individuals with asymptomatic and symptomatic giardiasis represented distinctive microbial diversity profiles, and that both were distinguishable from the profiles of healthy volunteers.
These findings identify a potential association between host microbiome disparity with the development of clinical disease during human giardiasis, and may provide insights into the mechanisms by which the parasite induces pathological changes in the gut. These observations may also lead to the development of novel selective therapeutic targets for preventing human enteric microbial infections. |
|---|---|
| AbstractList | BACKGROUND: The mechanisms underlying the clinical outcome disparity during human infection with Giardia duodenalis are still unclear. In recent years, evidence has pointed to the roles of host factors as well as parasite’s genetic heterogeneity as major contributing factors in the development of symptomatic human giardiasis. However, it remains contested as to how only a small fraction of individuals infected with G. duodenalis develop clinical gastrointestinal manifestations, whereas the majority of infected individuals remain asymptomatic. Here, we demonstrate that diversity in the fecal microbiome correlates with the clinical outcome of human giardiasis. METHODS: The genetic heterogeneity of G. duodenalis clinical isolates from human subjects with asymptomatic and symptomatic giardiasis was determined using a multilocus analysis approach. We also assessed the genetic proximity of G. duodenalis isolates by constructing phylogenetic trees using the maximum likelihood. Total genomic DNA (gDNA) from fecal specimens was utilized to construct DNA libraries, followed by performing paired-end sequencing using the HiSeq X platform. The Kraken2-generated, filtered FASTQ files were assigned to microbial metabolic pathways and functions using HUMAnN 3.04 and the UniRef90 diamond annotated full reference database (version 201901b). Results from HUMAnN for each sample were evaluated for differences among the biological groups using the Kruskal–Wallis non-parametric test with a post hoc Dunn test. RESULTS: We found that a total of 8/11 (72.73%) human subjects were infected with assemblage A (sub-assemblage AII) of G. duodenalis, whereas 3/11 (27.27%) human subjects in the current study were infected with assemblage B of the parasite. We also found that the parasite’s genetic diversity was not associated with the clinical outcome of the infection. Further phylogenetic analysis based on the tpi and gdh loci indicated that those clinical isolates belonging to assemblage A of G. duodenalis subjects clustered compactly together in a monophyletic clade despite being isolated from human subjects with asymptomatic and symptomatic human giardiasis. Using a metagenomic shotgun sequencing approach, we observed that infected individuals with asymptomatic and symptomatic giardiasis represented distinctive microbial diversity profiles, and that both were distinguishable from the profiles of healthy volunteers. CONCLUSIONS: These findings identify a potential association between host microbiome disparity with the development of clinical disease during human giardiasis, and may provide insights into the mechanisms by which the parasite induces pathological changes in the gut. These observations may also lead to the development of novel selective therapeutic targets for preventing human enteric microbial infections. The mechanisms underlying the clinical outcome disparity during human infection with Giardia duodenalis are still unclear. In recent years, evidence has pointed to the roles of host factors as well as parasite's genetic heterogeneity as major contributing factors in the development of symptomatic human giardiasis. However, it remains contested as to how only a small fraction of individuals infected with G. duodenalis develop clinical gastrointestinal manifestations, whereas the majority of infected individuals remain asymptomatic. Here, we demonstrate that diversity in the fecal microbiome correlates with the clinical outcome of human giardiasis. The genetic heterogeneity of G. duodenalis clinical isolates from human subjects with asymptomatic and symptomatic giardiasis was determined using a multilocus analysis approach. We also assessed the genetic proximity of G. duodenalis isolates by constructing phylogenetic trees using the maximum likelihood. Total genomic DNA (gDNA) from fecal specimens was utilized to construct DNA libraries, followed by performing paired-end sequencing using the HiSeq X platform. The Kraken2-generated, filtered FASTQ files were assigned to microbial metabolic pathways and functions using HUMAnN 3.04 and the UniRef90 diamond annotated full reference database (version 201901b). Results from HUMAnN for each sample were evaluated for differences among the biological groups using the Kruskal-Wallis non-parametric test with a post hoc Dunn test. We found that a total of 8/11 (72.73%) human subjects were infected with assemblage A (sub-assemblage AII) of G. duodenalis, whereas 3/11 (27.27%) human subjects in the current study were infected with assemblage B of the parasite. We also found that the parasite's genetic diversity was not associated with the clinical outcome of the infection. Further phylogenetic analysis based on the tpi and gdh loci indicated that those clinical isolates belonging to assemblage A of G. duodenalis subjects clustered compactly together in a monophyletic clade despite being isolated from human subjects with asymptomatic and symptomatic human giardiasis. Using a metagenomic shotgun sequencing approach, we observed that infected individuals with asymptomatic and symptomatic giardiasis represented distinctive microbial diversity profiles, and that both were distinguishable from the profiles of healthy volunteers. These findings identify a potential association between host microbiome disparity with the development of clinical disease during human giardiasis, and may provide insights into the mechanisms by which the parasite induces pathological changes in the gut. These observations may also lead to the development of novel selective therapeutic targets for preventing human enteric microbial infections. The mechanisms underlying the clinical outcome disparity during human infection with Giardia duodenalis are still unclear. In recent years, evidence has pointed to the roles of host factors as well as parasite's genetic heterogeneity as major contributing factors in the development of symptomatic human giardiasis. However, it remains contested as to how only a small fraction of individuals infected with G. duodenalis develop clinical gastrointestinal manifestations, whereas the majority of infected individuals remain asymptomatic. Here, we demonstrate that diversity in the fecal microbiome correlates with the clinical outcome of human giardiasis. The genetic heterogeneity of G. duodenalis clinical isolates from human subjects with asymptomatic and symptomatic giardiasis was determined using a multilocus analysis approach. We also assessed the genetic proximity of G. duodenalis isolates by constructing phylogenetic trees using the maximum likelihood. Total genomic DNA (gDNA) from fecal specimens was utilized to construct DNA libraries, followed by performing paired-end sequencing using the HiSeq X platform. The Kraken2-generated, filtered FASTQ files were assigned to microbial metabolic pathways and functions using HUMAnN 3.04 and the UniRef90 diamond annotated full reference database (version 201901b). Results from HUMAnN for each sample were evaluated for differences among the biological groups using the Kruskal-Wallis non-parametric test with a post hoc Dunn test. We found that a total of 8/11 (72.73%) human subjects were infected with assemblage A (sub-assemblage AII) of G. duodenalis, whereas 3/11 (27.27%) human subjects in the current study were infected with assemblage B of the parasite. We also found that the parasite's genetic diversity was not associated with the clinical outcome of the infection. Further phylogenetic analysis based on the tpi and gdh loci indicated that those clinical isolates belonging to assemblage A of G. duodenalis subjects clustered compactly together in a monophyletic clade despite being isolated from human subjects with asymptomatic and symptomatic human giardiasis. Using a metagenomic shotgun sequencing approach, we observed that infected individuals with asymptomatic and symptomatic giardiasis represented distinctive microbial diversity profiles, and that both were distinguishable from the profiles of healthy volunteers. These findings identify a potential association between host microbiome disparity with the development of clinical disease during human giardiasis, and may provide insights into the mechanisms by which the parasite induces pathological changes in the gut. These observations may also lead to the development of novel selective therapeutic targets for preventing human enteric microbial infections. Abstract Background The mechanisms underlying the clinical outcome disparity during human infection with Giardia duodenalis are still unclear. In recent years, evidence has pointed to the roles of host factors as well as parasite’s genetic heterogeneity as major contributing factors in the development of symptomatic human giardiasis. However, it remains contested as to how only a small fraction of individuals infected with G. duodenalis develop clinical gastrointestinal manifestations, whereas the majority of infected individuals remain asymptomatic. Here, we demonstrate that diversity in the fecal microbiome correlates with the clinical outcome of human giardiasis. Methods The genetic heterogeneity of G. duodenalis clinical isolates from human subjects with asymptomatic and symptomatic giardiasis was determined using a multilocus analysis approach. We also assessed the genetic proximity of G. duodenalis isolates by constructing phylogenetic trees using the maximum likelihood. Total genomic DNA (gDNA) from fecal specimens was utilized to construct DNA libraries, followed by performing paired-end sequencing using the HiSeq X platform. The Kraken2-generated, filtered FASTQ files were assigned to microbial metabolic pathways and functions using HUMAnN 3.04 and the UniRef90 diamond annotated full reference database (version 201901b). Results from HUMAnN for each sample were evaluated for differences among the biological groups using the Kruskal–Wallis non-parametric test with a post hoc Dunn test. Results We found that a total of 8/11 (72.73%) human subjects were infected with assemblage A (sub-assemblage AII) of G. duodenalis, whereas 3/11 (27.27%) human subjects in the current study were infected with assemblage B of the parasite. We also found that the parasite’s genetic diversity was not associated with the clinical outcome of the infection. Further phylogenetic analysis based on the tpi and gdh loci indicated that those clinical isolates belonging to assemblage A of G. duodenalis subjects clustered compactly together in a monophyletic clade despite being isolated from human subjects with asymptomatic and symptomatic human giardiasis. Using a metagenomic shotgun sequencing approach, we observed that infected individuals with asymptomatic and symptomatic giardiasis represented distinctive microbial diversity profiles, and that both were distinguishable from the profiles of healthy volunteers. Conclusions These findings identify a potential association between host microbiome disparity with the development of clinical disease during human giardiasis, and may provide insights into the mechanisms by which the parasite induces pathological changes in the gut. These observations may also lead to the development of novel selective therapeutic targets for preventing human enteric microbial infections. Graphical Abstract The mechanisms underlying the clinical outcome disparity during human infection with Giardia duodenalis are still unclear. In recent years, evidence has pointed to the roles of host factors as well as parasite's genetic heterogeneity as major contributing factors in the development of symptomatic human giardiasis. However, it remains contested as to how only a small fraction of individuals infected with G. duodenalis develop clinical gastrointestinal manifestations, whereas the majority of infected individuals remain asymptomatic. Here, we demonstrate that diversity in the fecal microbiome correlates with the clinical outcome of human giardiasis.BACKGROUNDThe mechanisms underlying the clinical outcome disparity during human infection with Giardia duodenalis are still unclear. In recent years, evidence has pointed to the roles of host factors as well as parasite's genetic heterogeneity as major contributing factors in the development of symptomatic human giardiasis. However, it remains contested as to how only a small fraction of individuals infected with G. duodenalis develop clinical gastrointestinal manifestations, whereas the majority of infected individuals remain asymptomatic. Here, we demonstrate that diversity in the fecal microbiome correlates with the clinical outcome of human giardiasis.The genetic heterogeneity of G. duodenalis clinical isolates from human subjects with asymptomatic and symptomatic giardiasis was determined using a multilocus analysis approach. We also assessed the genetic proximity of G. duodenalis isolates by constructing phylogenetic trees using the maximum likelihood. Total genomic DNA (gDNA) from fecal specimens was utilized to construct DNA libraries, followed by performing paired-end sequencing using the HiSeq X platform. The Kraken2-generated, filtered FASTQ files were assigned to microbial metabolic pathways and functions using HUMAnN 3.04 and the UniRef90 diamond annotated full reference database (version 201901b). Results from HUMAnN for each sample were evaluated for differences among the biological groups using the Kruskal-Wallis non-parametric test with a post hoc Dunn test.METHODSThe genetic heterogeneity of G. duodenalis clinical isolates from human subjects with asymptomatic and symptomatic giardiasis was determined using a multilocus analysis approach. We also assessed the genetic proximity of G. duodenalis isolates by constructing phylogenetic trees using the maximum likelihood. Total genomic DNA (gDNA) from fecal specimens was utilized to construct DNA libraries, followed by performing paired-end sequencing using the HiSeq X platform. The Kraken2-generated, filtered FASTQ files were assigned to microbial metabolic pathways and functions using HUMAnN 3.04 and the UniRef90 diamond annotated full reference database (version 201901b). Results from HUMAnN for each sample were evaluated for differences among the biological groups using the Kruskal-Wallis non-parametric test with a post hoc Dunn test.We found that a total of 8/11 (72.73%) human subjects were infected with assemblage A (sub-assemblage AII) of G. duodenalis, whereas 3/11 (27.27%) human subjects in the current study were infected with assemblage B of the parasite. We also found that the parasite's genetic diversity was not associated with the clinical outcome of the infection. Further phylogenetic analysis based on the tpi and gdh loci indicated that those clinical isolates belonging to assemblage A of G. duodenalis subjects clustered compactly together in a monophyletic clade despite being isolated from human subjects with asymptomatic and symptomatic human giardiasis. Using a metagenomic shotgun sequencing approach, we observed that infected individuals with asymptomatic and symptomatic giardiasis represented distinctive microbial diversity profiles, and that both were distinguishable from the profiles of healthy volunteers.RESULTSWe found that a total of 8/11 (72.73%) human subjects were infected with assemblage A (sub-assemblage AII) of G. duodenalis, whereas 3/11 (27.27%) human subjects in the current study were infected with assemblage B of the parasite. We also found that the parasite's genetic diversity was not associated with the clinical outcome of the infection. Further phylogenetic analysis based on the tpi and gdh loci indicated that those clinical isolates belonging to assemblage A of G. duodenalis subjects clustered compactly together in a monophyletic clade despite being isolated from human subjects with asymptomatic and symptomatic human giardiasis. Using a metagenomic shotgun sequencing approach, we observed that infected individuals with asymptomatic and symptomatic giardiasis represented distinctive microbial diversity profiles, and that both were distinguishable from the profiles of healthy volunteers.These findings identify a potential association between host microbiome disparity with the development of clinical disease during human giardiasis, and may provide insights into the mechanisms by which the parasite induces pathological changes in the gut. These observations may also lead to the development of novel selective therapeutic targets for preventing human enteric microbial infections.CONCLUSIONSThese findings identify a potential association between host microbiome disparity with the development of clinical disease during human giardiasis, and may provide insights into the mechanisms by which the parasite induces pathological changes in the gut. These observations may also lead to the development of novel selective therapeutic targets for preventing human enteric microbial infections. BackgroundThe mechanisms underlying the clinical outcome disparity during human infection with Giardia duodenalis are still unclear. In recent years, evidence has pointed to the roles of host factors as well as parasite’s genetic heterogeneity as major contributing factors in the development of symptomatic human giardiasis. However, it remains contested as to how only a small fraction of individuals infected with G. duodenalis develop clinical gastrointestinal manifestations, whereas the majority of infected individuals remain asymptomatic. Here, we demonstrate that diversity in the fecal microbiome correlates with the clinical outcome of human giardiasis.MethodsThe genetic heterogeneity of G. duodenalis clinical isolates from human subjects with asymptomatic and symptomatic giardiasis was determined using a multilocus analysis approach. We also assessed the genetic proximity of G. duodenalis isolates by constructing phylogenetic trees using the maximum likelihood. Total genomic DNA (gDNA) from fecal specimens was utilized to construct DNA libraries, followed by performing paired-end sequencing using the HiSeq X platform. The Kraken2-generated, filtered FASTQ files were assigned to microbial metabolic pathways and functions using HUMAnN 3.04 and the UniRef90 diamond annotated full reference database (version 201901b). Results from HUMAnN for each sample were evaluated for differences among the biological groups using the Kruskal–Wallis non-parametric test with a post hoc Dunn test.ResultsWe found that a total of 8/11 (72.73%) human subjects were infected with assemblage A (sub-assemblage AII) of G. duodenalis, whereas 3/11 (27.27%) human subjects in the current study were infected with assemblage B of the parasite. We also found that the parasite’s genetic diversity was not associated with the clinical outcome of the infection. Further phylogenetic analysis based on the tpi and gdh loci indicated that those clinical isolates belonging to assemblage A of G. duodenalis subjects clustered compactly together in a monophyletic clade despite being isolated from human subjects with asymptomatic and symptomatic human giardiasis. Using a metagenomic shotgun sequencing approach, we observed that infected individuals with asymptomatic and symptomatic giardiasis represented distinctive microbial diversity profiles, and that both were distinguishable from the profiles of healthy volunteers.ConclusionsThese findings identify a potential association between host microbiome disparity with the development of clinical disease during human giardiasis, and may provide insights into the mechanisms by which the parasite induces pathological changes in the gut. These observations may also lead to the development of novel selective therapeutic targets for preventing human enteric microbial infections. Background The mechanisms underlying the clinical outcome disparity during human infection with Giardia duodenalis are still unclear. In recent years, evidence has pointed to the roles of host factors as well as parasite's genetic heterogeneity as major contributing factors in the development of symptomatic human giardiasis. However, it remains contested as to how only a small fraction of individuals infected with G. duodenalis develop clinical gastrointestinal manifestations, whereas the majority of infected individuals remain asymptomatic. Here, we demonstrate that diversity in the fecal microbiome correlates with the clinical outcome of human giardiasis. Methods The genetic heterogeneity of G. duodenalis clinical isolates from human subjects with asymptomatic and symptomatic giardiasis was determined using a multilocus analysis approach. We also assessed the genetic proximity of G. duodenalis isolates by constructing phylogenetic trees using the maximum likelihood. Total genomic DNA (gDNA) from fecal specimens was utilized to construct DNA libraries, followed by performing paired-end sequencing using the HiSeq X platform. The Kraken2-generated, filtered FASTQ files were assigned to microbial metabolic pathways and functions using HUMAnN 3.04 and the UniRef90 diamond annotated full reference database (version 201901b). Results from HUMAnN for each sample were evaluated for differences among the biological groups using the Kruskal-Wallis non-parametric test with a post hoc Dunn test. Results We found that a total of 8/11 (72.73%) human subjects were infected with assemblage A (sub-assemblage AII) of G. duodenalis, whereas 3/11 (27.27%) human subjects in the current study were infected with assemblage B of the parasite. We also found that the parasite's genetic diversity was not associated with the clinical outcome of the infection. Further phylogenetic analysis based on the tpi and gdh loci indicated that those clinical isolates belonging to assemblage A of G. duodenalis subjects clustered compactly together in a monophyletic clade despite being isolated from human subjects with asymptomatic and symptomatic human giardiasis. Using a metagenomic shotgun sequencing approach, we observed that infected individuals with asymptomatic and symptomatic giardiasis represented distinctive microbial diversity profiles, and that both were distinguishable from the profiles of healthy volunteers. Conclusions These findings identify a potential association between host microbiome disparity with the development of clinical disease during human giardiasis, and may provide insights into the mechanisms by which the parasite induces pathological changes in the gut. These observations may also lead to the development of novel selective therapeutic targets for preventing human enteric microbial infections. Graphical Keywords: Human, Giardiasis, Gut, Microbiome, Infection, Mucosal |
| ArticleNumber | 239 |
| Audience | Academic |
| Author | Golovko, Mikhail Y. Hur, Junguk Golovko, Svetlana A. McGregor, Brett A. Singer, Steven M. Hooshyar, Hossein Razmjou, Elham Seeger, Drew R. Solaymani-Mohammadi, Shahram |
| Author_xml | – sequence: 1 givenname: Brett A. surname: McGregor fullname: McGregor, Brett A. – sequence: 2 givenname: Elham surname: Razmjou fullname: Razmjou, Elham – sequence: 3 givenname: Hossein surname: Hooshyar fullname: Hooshyar, Hossein – sequence: 4 givenname: Drew R. surname: Seeger fullname: Seeger, Drew R. – sequence: 5 givenname: Svetlana A. surname: Golovko fullname: Golovko, Svetlana A. – sequence: 6 givenname: Mikhail Y. surname: Golovko fullname: Golovko, Mikhail Y. – sequence: 7 givenname: Steven M. surname: Singer fullname: Singer, Steven M. – sequence: 8 givenname: Junguk surname: Hur fullname: Hur, Junguk – sequence: 9 givenname: Shahram surname: Solaymani-Mohammadi fullname: Solaymani-Mohammadi, Shahram |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37464386$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkktv1DAUhSNURB_wB1ggS2xgkeK3nRUaVVBGqoTEY23d2M6MR0lcYgfov8cz00KnQiAvbN373SP7-JxWR2McfVU9J_icEC3fJMKwIjWmrMZCU1KTR9UJUULWjGFxdO98XJ2mtMFY4kbIJ9UxU1xypuVJBQuU1jGv5hENPsPKj3EIFsEI_U0KCcUO5bVHnbfQo9KZYhvi4FEY0XoeYEzlVJrZO_Qj5DW6DDC5AMjN0fkiEtLT6nEHffLPbvez6uv7d18uPtRXHy-XF4ur2kpGct1xrxvZ4Y61ICUw4IxK1uLGaqdFwxUHKp11rdUKO0U1bbmQnXVSYEkJZWfVcq_rImzM9RQGmG5MhGB2hTitDEw52N6bRrSq6ZyzWlAOsmmlp1J3wDkXpGOiaL3da13P7eCd9WOeoD8QPeyMYW1W8bshmAne0K3Cq1uFKX6bfcpmCMn6vofRxzkZRgRTmGP1f5Rq1ihOZEMK-vIBuonzVGzeUVppLZX-Q62gPLb8Tyx3tFtRs1BCKVqMVYU6_wtVlvPln0vSulDqBwOvDwYKk_3PvII5JbP8_OmQfXHfwN_O3QWvAHoPlESlNPnO2JAhh7j1M_TFSLPNuNln3JSMm13GzdYE-mD0Tv0fQ78AWk76_w |
| CitedBy_id | crossref_primary_10_1007_s40475_024_00314_2 crossref_primary_10_1136_gutjnl_2023_331835 crossref_primary_10_4103_jcrt_jcrt_33_24 crossref_primary_10_3389_fcimb_2025_1555171 crossref_primary_10_1016_j_lfs_2024_123182 |
| Cites_doi | 10.1016/S0020-7519(02)00068-1 10.4049/jimmunol.176.1.516 10.1021/bi9822933 10.1128/IAI.72.6.3536-3542.2004 10.1016/S0020-7519(00)00127-2 10.1007/s00436-021-07325-2 10.1104/pp.102.018846 10.4269/ajtmh.1989.41.512 10.1007/s10096-007-0404-3 10.1080/1040-840291046713 10.1046/j.1440-1746.2000.02089.x 10.1186/s13071-020-04073-7 10.1016/j.micinf.2015.03.006 10.1186/s13071-015-1059-z 10.1016/j.meegid.2013.04.013 10.1179/136485908X355247 10.1038/mi.2012.80 10.1016/j.neurobiolaging.2020.04.009 10.1016/j.exppara.2010.06.014 10.1128/IAI.68.6.3412-3418.2000 10.1016/j.ygeno.2022.110462 10.1017/S0031182020001821 10.1038/s41598-019-56416-9 10.1017/S0031182018000409 10.3390/pathogens10020206 10.1016/j.biopha.2018.02.141 10.1128/IAI.00718-08 10.1016/j.meegid.2014.01.007 10.1038/s41586-020-2193-0 10.3389/fpls.2020.589026 10.3389/fimmu.2019.02718 10.1080/21505594.2018.1451284 10.1186/1757-4749-5-26 10.1016/j.actatropica.2007.04.003 10.3855/jidc.8179 10.1017/S0031182009990436 10.1007/s10096-015-2389-7 10.1128/CMR.14.3.447-475.2001 10.3389/fimmu.2022.817468 10.1007/s00436-016-5196-x 10.1371/journal.pone.0240119 10.1099/0022-1317-49-3-209 10.4049/jimmunol.164.3.1478 10.1038/s41586-019-1785-z 10.3389/fmed.2022.976956 10.1128/IAI.70.7.3673-3680.2002 10.1093/cid/ciaa128 10.1152/ajpgi.00144.2015 10.3390/ijms22147451 10.1371/journal.pntd.0009277 10.1111/j.1440-1746.2007.05289.x 10.1007/s12602-018-9506-8 10.3109/00365529709025062 10.1128/CMR.00033-10 10.12659/MSM.892318 10.1016/j.ijpara.2004.10.022 10.3389/fmicb.2017.02707 10.1016/j.cell.2013.06.041 10.1007/s12639-020-01338-x 10.1016/j.meegid.2017.12.001 10.1371/journal.pone.0143981 10.1016/j.ijpara.2007.07.016 10.1128/IAI.00948-16 10.4269/ajtmh.1994.50.705 10.1371/journal.pntd.0008987 10.7554/eLife.65088 10.3201/eid1701.P11101 10.1016/0016-5085(95)90383-6 10.4049/jimmunol.1100606 10.1128/IAI.00348-16 10.1073/pnas.0606195103 10.1016/j.ijpara.2016.11.010 10.1086/498169 10.1016/j.micinf.2016.06.009 10.1038/s41598-021-98262-8 10.1016/0020-7519(90)90133-8 10.1086/315409 10.1016/j.meegid.2004.02.001 10.1016/j.mimet.2017.07.004 10.1371/journal.pntd.0006120 10.1128/mSphere.00670-20 10.3201/eid0911.030084 10.1128/IAI.00004-13 |
| ContentType | Journal Article |
| Copyright | 2023. The Author(s). COPYRIGHT 2023 BioMed Central Ltd. 2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s) 2023 |
| Copyright_xml | – notice: 2023. The Author(s). – notice: COPYRIGHT 2023 BioMed Central Ltd. – notice: 2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s) 2023 |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM ISR 3V. 7SN 7SS 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR C1K CCPQU DWQXO F1W FYUFA GHDGH H95 K9. L.G M0S M1P M7N PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI 7X8 7S9 L.6 5PM DOA |
| DOI | 10.1186/s13071-023-05821-1 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Gale In Context: Science ProQuest Central (Corporate) Ecology Abstracts Entomology Abstracts (Full archive) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central Environmental Sciences and Pollution Management ProQuest One ProQuest Central ASFA: Aquatic Sciences and Fisheries Abstracts Health Research Premium Collection Health Research Premium Collection (Alumni) Aquatic Science & Fisheries Abstracts (ASFA) 1: Biological Sciences & Living Resources ProQuest Health & Medical Complete (Alumni) Aquatic Science & Fisheries Abstracts (ASFA) Professional Health & Medical Collection (Alumni) Medical Database Algology Mycology and Protozoology Abstracts (Microbiology C) ProQuest Central Premium ProQuest One Academic (New) ProQuest Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition MEDLINE - Academic AGRICOLA AGRICOLA - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database Aquatic Science & Fisheries Abstracts (ASFA) Professional ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Environmental Sciences and Pollution Management ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Algology Mycology and Protozoology Abstracts (Microbiology C) Health & Medical Research Collection Aquatic Science & Fisheries Abstracts (ASFA) 1: Biological Sciences & Living Resources ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Ecology Abstracts ProQuest Hospital Collection (Alumni) Entomology Abstracts ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ASFA: Aquatic Sciences and Fisheries Abstracts ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
| DatabaseTitleList | AGRICOLA MEDLINE MEDLINE - Academic Publicly Available Content Database |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Zoology |
| EISSN | 1756-3305 |
| EndPage | 239 |
| ExternalDocumentID | oai_doaj_org_article_95b79fddc8524a69b6e268fa44451f35 PMC10354925 A757722637 37464386 10_1186_s13071_023_05821_1 |
| Genre | Journal Article |
| GeographicLocations | United States United States--US |
| GeographicLocations_xml | – name: United States – name: United States--US |
| GrantInformation_xml | – fundername: NIH HHS grantid: NIH/NIGMSP20GM113123 – fundername: NIGMS NIH HHS grantid: P20 GM113123 – fundername: NINDS NIH HHS grantid: R01 NS119279 – fundername: NIAID NIH HHS grantid: R21 AI166467 – fundername: NIAID NIH HHS grantid: R15 AI109591 – fundername: ; grantid: NIH/NIGMSP20GM113123; NIH/NIGMSP20GM113123; NIH/NIGMSP20GM113123 – fundername: ; grantid: 20344-8015 |
| GroupedDBID | --- 0R~ 123 29O 2WC 2XV 53G 5VS 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAYXX ABDBF ABUWG ACGFS ACIHN ACPRK ACUHS ADBBV ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AFRAH AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CITATION CS3 DIK DU5 E3Z EBD EBLON EBS ECGQY EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR INH INR ISR ITC KQ8 M1P M48 M~E O5R O5S OK1 OVT PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RBZ RNS ROL RPM RSV SBL SOJ SV3 TR2 TUS UKHRP ~8M CGR CUY CVF ECM EIF NPM PJZUB PPXIY PMFND 3V. 7SN 7SS 7XB 8FK AZQEC C1K DWQXO F1W H95 K9. L.G M7N PKEHL PQEST PQUKI 7X8 7S9 L.6 5PM PUEGO |
| ID | FETCH-LOGICAL-c631t-f4e896f0f3ba66a3a43263b09c8d859474a26dcdbc870d7282b456fcd65062123 |
| IEDL.DBID | M48 |
| ISSN | 1756-3305 |
| IngestDate | Wed Aug 27 01:31:53 EDT 2025 Thu Aug 21 18:36:36 EDT 2025 Fri Jul 11 09:54:30 EDT 2025 Fri Jul 11 07:58:13 EDT 2025 Sat Jul 26 00:13:14 EDT 2025 Tue Jun 17 20:55:18 EDT 2025 Tue Jun 10 21:27:41 EDT 2025 Fri Jun 27 06:03:58 EDT 2025 Mon Jul 21 05:59:22 EDT 2025 Tue Jul 01 00:54:14 EDT 2025 Thu Apr 24 23:07:40 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Human Infection Mucosal Giardiasis Gut Microbiome |
| Language | English |
| License | 2023. The Author(s). Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c631t-f4e896f0f3ba66a3a43263b09c8d859474a26dcdbc870d7282b456fcd65062123 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| OpenAccessLink | https://doaj.org/article/95b79fddc8524a69b6e268fa44451f35 |
| PMID | 37464386 |
| PQID | 2838788678 |
| PQPubID | 55241 |
| PageCount | 1 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_95b79fddc8524a69b6e268fa44451f35 pubmedcentral_primary_oai_pubmedcentral_nih_gov_10354925 proquest_miscellaneous_3153704075 proquest_miscellaneous_2839741691 proquest_journals_2838788678 gale_infotracmisc_A757722637 gale_infotracacademiconefile_A757722637 gale_incontextgauss_ISR_A757722637 pubmed_primary_37464386 crossref_citationtrail_10_1186_s13071_023_05821_1 crossref_primary_10_1186_s13071_023_05821_1 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2023-07-18 |
| PublicationDateYYYYMMDD | 2023-07-18 |
| PublicationDate_xml | – month: 07 year: 2023 text: 2023-07-18 day: 18 |
| PublicationDecade | 2020 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: London |
| PublicationTitle | Parasites & vectors |
| PublicationTitleAlternate | Parasit Vectors |
| PublicationYear | 2023 |
| Publisher | BioMed Central Ltd BioMed Central BMC |
| Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
| References | A Woschke (5821_CR17) 2021; 15 A Messa Jr (5821_CR26) 2021; 15 A Keselman (5821_CR34) 2016; 84 Y Feng (5821_CR15) 2011; 24 ASF Berry (5821_CR40) 2020; 5 IA Yordanova (5821_CR42) 2019; 9 H Elhadad (5821_CR62) 2021; 45 SC Lu (5821_CR82) 2008; 1 SM Cacciò (5821_CR54) 2002; 32 G Oberhuber (5821_CR69) 1997; 32 S Banik (5821_CR67) 2013; 81 C Yerinde (5821_CR83) 2019; 10 J Maloney (5821_CR73) 2015; 17 A Cevallos (5821_CR30) 1995; 109 5821_CR58 C Schalk-Hihi (5821_CR81) 1999; 38 MG Kocsis (5821_CR80) 2003; 131 V Iebba (5821_CR37) 2016; 10 T Geurden (5821_CR53) 2008; 38 S Solaymani-Mohammadi (5821_CR2) 2010; 126 RC Thompson (5821_CR6) 2000; 30 T Allain (5821_CR48) 2021; 11 ME Hellard (5821_CR7) 2000; 15 H Kaur (5821_CR59) 2020; 92 F Beghini (5821_CR57) 2021; 10 KD Kappus (5821_CR8) 1994; 50 L Eckmann (5821_CR71) 2000; 164 T Gelanew (5821_CR23) 2007; 102 G Shukla (5821_CR44) 2016; 115 G Shukla (5821_CR46) 2020; 12 L Pelayo (5821_CR25) 2008; 102 CM Read (5821_CR60) 2004; 4 T Geurden (5821_CR51) 2009; 136 HM Fahmy (5821_CR63) 2015; 34 E Li (5821_CR72) 2006; 176 PC Köster (5821_CR28) 2021; 10 W Cai (5821_CR16) 2021; 120 C Minetti (5821_CR20) 2015; 8 MF Pavanelli (5821_CR41) 2018; 101 J Sahagún (5821_CR61) 2008; 27 CS Huey (5821_CR52) 2013; 17 SM Singer (5821_CR35) 2000; 181 JD Kamda (5821_CR66) 2009; 77 C Campbell (5821_CR76) 2020; 581 AC Chin (5821_CR29) 2002; 70 JK Beatty (5821_CR65) 2017; 47 S Solaymani-Mohammadi (5821_CR3) 2022; 13 S Solaymani-Mohammadi (5821_CR11) 2011; 187 A de Lucio (5821_CR18) 2015; 10 S Hang (5821_CR77) 2019; 576 MF Torres (5821_CR36) 2000; 49 SM Cacciò (5821_CR14) 2018; 66 BM Sutter (5821_CR84) 2013; 154 NR Barash (5821_CR56) 2017; 85 Z Babaei (5821_CR12) 2016; 18 CM Coffey (5821_CR10) 2021; 72 TL Chen (5821_CR43) 2013; 5 PJ Schofield (5821_CR70) 1990; 20 L Lecová (5821_CR21) 2018; 145 M Lalle (5821_CR55) 2005; 35 RD Adam (5821_CR1) 2001; 14 GS Tamer (5821_CR64) 2015; 21 LJ Puebla (5821_CR24) 2014; 23 Y Pan (5821_CR79) 2020; 11 S Solaymani-Mohammadi (5821_CR31) 2013; 6 S Hashemi-Hafshejani (5821_CR49) 2022; 9 M Nooshadokht (5821_CR13) 2017; 141 GJ Leitch (5821_CR47) 1989; 41 F Rébeillé (5821_CR78) 2006; 103 MC Halliez (5821_CR38) 2016; 310 F Sarzhanov (5821_CR27) 2021; 148 IM Sulaiman (5821_CR50) 2003; 9 AA Ahmad (5821_CR19) 2020; 15 JS Yoder (5821_CR4) 2012; 6 R Mejia (5821_CR39) 2020; 13 R Haque (5821_CR22) 2005; 192 KG Scott (5821_CR32) 2000; 68 T Allain (5821_CR45) 2018; 8 J Liu (5821_CR74) 2018; 9 KG Scott (5821_CR33) 2004; 72 M Rodríguez-Walker (5821_CR68) 2022; 114 SY Ma'ayeh (5821_CR75) 2017; 11 S Lane (5821_CR5) 2002; 28 E Scallan (5821_CR9) 2011; 17 |
| References_xml | – volume: 32 start-page: 1023 year: 2002 ident: 5821_CR54 publication-title: Int J Parasitol doi: 10.1016/S0020-7519(02)00068-1 – volume: 176 start-page: 516 year: 2006 ident: 5821_CR72 publication-title: J Immunol doi: 10.4049/jimmunol.176.1.516 – volume: 38 start-page: 2542 year: 1999 ident: 5821_CR81 publication-title: Biochemistry doi: 10.1021/bi9822933 – volume: 72 start-page: 3536 year: 2004 ident: 5821_CR33 publication-title: Infect Immun doi: 10.1128/IAI.72.6.3536-3542.2004 – volume: 30 start-page: 1259 year: 2000 ident: 5821_CR6 publication-title: Int J Parasitol doi: 10.1016/S0020-7519(00)00127-2 – volume: 120 start-page: 4199 year: 2021 ident: 5821_CR16 publication-title: Parasitol Res doi: 10.1007/s00436-021-07325-2 – volume: 131 start-page: 1808 year: 2003 ident: 5821_CR80 publication-title: Plant Physiol doi: 10.1104/pp.102.018846 – volume: 41 start-page: 512 year: 1989 ident: 5821_CR47 publication-title: Am J Trop Med Hyg doi: 10.4269/ajtmh.1989.41.512 – volume: 27 start-page: 81 year: 2008 ident: 5821_CR61 publication-title: Eur J Clin Microbiol Infect Dis doi: 10.1007/s10096-007-0404-3 – volume: 28 start-page: 123 year: 2002 ident: 5821_CR5 publication-title: Crit Rev Microbiol doi: 10.1080/1040-840291046713 – volume: 15 start-page: 290 year: 2000 ident: 5821_CR7 publication-title: J Gastroenterol Hepatol doi: 10.1046/j.1440-1746.2000.02089.x – volume: 13 start-page: 200 year: 2020 ident: 5821_CR39 publication-title: Parasit Vectors doi: 10.1186/s13071-020-04073-7 – volume: 17 start-page: 462 year: 2015 ident: 5821_CR73 publication-title: Microbes Infect doi: 10.1016/j.micinf.2015.03.006 – volume: 8 start-page: 444 year: 2015 ident: 5821_CR20 publication-title: Parasit Vectors doi: 10.1186/s13071-015-1059-z – volume: 17 start-page: 269 year: 2013 ident: 5821_CR52 publication-title: Infect Genet Evol doi: 10.1016/j.meegid.2013.04.013 – volume: 102 start-page: 585 year: 2008 ident: 5821_CR25 publication-title: Ann Trop Med Parasitol doi: 10.1179/136485908X355247 – volume: 6 start-page: 369 year: 2013 ident: 5821_CR31 publication-title: Mucosal Immunol doi: 10.1038/mi.2012.80 – volume: 92 start-page: 114 year: 2020 ident: 5821_CR59 publication-title: Neurobiol Aging doi: 10.1016/j.neurobiolaging.2020.04.009 – volume: 126 start-page: 292 year: 2010 ident: 5821_CR2 publication-title: Exp Parasitol doi: 10.1016/j.exppara.2010.06.014 – volume: 68 start-page: 3412 year: 2000 ident: 5821_CR32 publication-title: Infect Immun doi: 10.1128/IAI.68.6.3412-3418.2000 – volume: 114 year: 2022 ident: 5821_CR68 publication-title: Genomics doi: 10.1016/j.ygeno.2022.110462 – volume: 148 start-page: 550 year: 2021 ident: 5821_CR27 publication-title: Parasitology doi: 10.1017/S0031182020001821 – volume: 9 start-page: 20328 year: 2019 ident: 5821_CR42 publication-title: Sci Rep doi: 10.1038/s41598-019-56416-9 – volume: 145 start-page: 1577 year: 2018 ident: 5821_CR21 publication-title: Parasitology doi: 10.1017/S0031182018000409 – volume: 10 start-page: 206 year: 2021 ident: 5821_CR28 publication-title: Brazilian Amazon Pathogens doi: 10.3390/pathogens10020206 – volume: 101 start-page: 563 year: 2018 ident: 5821_CR41 publication-title: Biomed Pharmacother doi: 10.1016/j.biopha.2018.02.141 – volume: 77 start-page: 685 year: 2009 ident: 5821_CR66 publication-title: Infect Immun doi: 10.1128/IAI.00718-08 – volume: 23 start-page: 7 year: 2014 ident: 5821_CR24 publication-title: Infect Genet Evol doi: 10.1016/j.meegid.2014.01.007 – volume: 581 start-page: 475 year: 2020 ident: 5821_CR76 publication-title: Nature doi: 10.1038/s41586-020-2193-0 – volume: 11 year: 2020 ident: 5821_CR79 publication-title: Front Plant Sci doi: 10.3389/fpls.2020.589026 – volume: 10 start-page: 2718 year: 2019 ident: 5821_CR83 publication-title: Front Immunol doi: 10.3389/fimmu.2019.02718 – volume: 9 start-page: 879 year: 2018 ident: 5821_CR74 publication-title: Virulence doi: 10.1080/21505594.2018.1451284 – volume: 5 start-page: 26 year: 2013 ident: 5821_CR43 publication-title: Gut Pathog doi: 10.1186/1757-4749-5-26 – volume: 102 start-page: 92 year: 2007 ident: 5821_CR23 publication-title: Acta Trop doi: 10.1016/j.actatropica.2007.04.003 – volume: 10 start-page: 1035 year: 2016 ident: 5821_CR37 publication-title: J Infect Dev Ctries doi: 10.3855/jidc.8179 – volume: 136 start-page: 1161 year: 2009 ident: 5821_CR51 publication-title: Parasitology doi: 10.1017/S0031182009990436 – volume: 34 start-page: 1573 year: 2015 ident: 5821_CR63 publication-title: Eur J Clin Microbiol Infect Dis doi: 10.1007/s10096-015-2389-7 – volume: 14 start-page: 447 year: 2001 ident: 5821_CR1 publication-title: Clin Microbiol Rev doi: 10.1128/CMR.14.3.447-475.2001 – volume: 13 start-page: 817468 year: 2022 ident: 5821_CR3 publication-title: Front Immunol doi: 10.3389/fimmu.2022.817468 – volume: 115 start-page: 4189 year: 2016 ident: 5821_CR44 publication-title: Parasitol Res doi: 10.1007/s00436-016-5196-x – volume: 15 year: 2020 ident: 5821_CR19 publication-title: PLoS ONE doi: 10.1371/journal.pone.0240119 – volume: 49 start-page: 209 year: 2000 ident: 5821_CR36 publication-title: J Med Microbiol doi: 10.1099/0022-1317-49-3-209 – volume: 164 start-page: 1478 year: 2000 ident: 5821_CR71 publication-title: J Immunol doi: 10.4049/jimmunol.164.3.1478 – volume: 576 start-page: 143 year: 2019 ident: 5821_CR77 publication-title: Nature doi: 10.1038/s41586-019-1785-z – volume: 9 year: 2022 ident: 5821_CR49 publication-title: Front Med doi: 10.3389/fmed.2022.976956 – volume: 70 start-page: 3673 year: 2002 ident: 5821_CR29 publication-title: Infect Immun doi: 10.1128/IAI.70.7.3673-3680.2002 – volume: 72 start-page: 764 year: 2021 ident: 5821_CR10 publication-title: Clin Infect Dis doi: 10.1093/cid/ciaa128 – volume: 310 start-page: G574 year: 2016 ident: 5821_CR38 publication-title: Am J Physiol Gastrointest Liver Physiol doi: 10.1152/ajpgi.00144.2015 – ident: 5821_CR58 doi: 10.3390/ijms22147451 – volume: 15 year: 2021 ident: 5821_CR17 publication-title: PLoS Negl Trop Dis doi: 10.1371/journal.pntd.0009277 – volume: 1 start-page: S73 year: 2008 ident: 5821_CR82 publication-title: J Gastroenterol Hepatol doi: 10.1111/j.1440-1746.2007.05289.x – volume: 12 start-page: 271 year: 2020 ident: 5821_CR46 publication-title: Probiotics Antimicrob Proteins doi: 10.1007/s12602-018-9506-8 – volume: 32 start-page: 48 year: 1997 ident: 5821_CR69 publication-title: Scand J Gastroenterol doi: 10.3109/00365529709025062 – volume: 24 start-page: 110 year: 2011 ident: 5821_CR15 publication-title: Clin Microbiol Rev doi: 10.1128/CMR.00033-10 – volume: 21 start-page: 526 year: 2015 ident: 5821_CR64 publication-title: Med Sci Monit doi: 10.12659/MSM.892318 – volume: 35 start-page: 207 year: 2005 ident: 5821_CR55 publication-title: Int J Parasitol doi: 10.1016/j.ijpara.2004.10.022 – volume: 8 start-page: 2707 year: 2018 ident: 5821_CR45 publication-title: Front Microbiol doi: 10.3389/fmicb.2017.02707 – volume: 154 start-page: 403 year: 2013 ident: 5821_CR84 publication-title: Cell doi: 10.1016/j.cell.2013.06.041 – volume: 45 start-page: 655 year: 2021 ident: 5821_CR62 publication-title: J Parasit Dis doi: 10.1007/s12639-020-01338-x – volume: 6 start-page: 13 year: 2012 ident: 5821_CR4 publication-title: MMWR Surveill Summ – volume: 66 start-page: 335 year: 2018 ident: 5821_CR14 publication-title: Infect Genet Evol doi: 10.1016/j.meegid.2017.12.001 – volume: 10 year: 2015 ident: 5821_CR18 publication-title: Spain PLoS One doi: 10.1371/journal.pone.0143981 – volume: 38 start-page: 259 year: 2008 ident: 5821_CR53 publication-title: Int J Parasitol doi: 10.1016/j.ijpara.2007.07.016 – volume: 85 start-page: e00948 year: 2017 ident: 5821_CR56 publication-title: Infect Immun doi: 10.1128/IAI.00948-16 – volume: 50 start-page: 705 year: 1994 ident: 5821_CR8 publication-title: Am J Trop Med Hyg doi: 10.4269/ajtmh.1994.50.705 – volume: 15 year: 2021 ident: 5821_CR26 publication-title: PLoS Negl Trop Dis doi: 10.1371/journal.pntd.0008987 – volume: 10 year: 2021 ident: 5821_CR57 publication-title: Elife doi: 10.7554/eLife.65088 – volume: 17 start-page: 7 year: 2011 ident: 5821_CR9 publication-title: Emerg Infect Dis doi: 10.3201/eid1701.P11101 – volume: 109 start-page: 766 year: 1995 ident: 5821_CR30 publication-title: Gastroenterology doi: 10.1016/0016-5085(95)90383-6 – volume: 187 start-page: 3769 year: 2011 ident: 5821_CR11 publication-title: J Immunol doi: 10.4049/jimmunol.1100606 – volume: 84 start-page: 2853 year: 2016 ident: 5821_CR34 publication-title: Infect Immun doi: 10.1128/IAI.00348-16 – volume: 103 start-page: 15687 year: 2006 ident: 5821_CR78 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0606195103 – volume: 47 start-page: 311 year: 2017 ident: 5821_CR65 publication-title: Int J Parasitol doi: 10.1016/j.ijpara.2016.11.010 – volume: 192 start-page: 2171 year: 2005 ident: 5821_CR22 publication-title: J Infect Dis doi: 10.1086/498169 – volume: 18 start-page: 687 year: 2016 ident: 5821_CR12 publication-title: Microbes Infect doi: 10.1016/j.micinf.2016.06.009 – volume: 11 start-page: 18842 year: 2021 ident: 5821_CR48 publication-title: Sci Rep doi: 10.1038/s41598-021-98262-8 – volume: 20 start-page: 697 year: 1990 ident: 5821_CR70 publication-title: Int J Parasitol doi: 10.1016/0020-7519(90)90133-8 – volume: 181 start-page: 1510 year: 2000 ident: 5821_CR35 publication-title: J Infect Dis doi: 10.1086/315409 – volume: 4 start-page: 125 year: 2004 ident: 5821_CR60 publication-title: Infect Genet Evol doi: 10.1016/j.meegid.2004.02.001 – volume: 141 start-page: 35 year: 2017 ident: 5821_CR13 publication-title: J Microbiol Methods doi: 10.1016/j.mimet.2017.07.004 – volume: 11 year: 2017 ident: 5821_CR75 publication-title: PLoS Negl Trop Dis doi: 10.1371/journal.pntd.0006120 – volume: 5 start-page: e00670 year: 2020 ident: 5821_CR40 publication-title: mSphere doi: 10.1128/mSphere.00670-20 – volume: 9 start-page: 1444 year: 2003 ident: 5821_CR50 publication-title: Emerg Infect Dis doi: 10.3201/eid0911.030084 – volume: 81 start-page: 2309 year: 2013 ident: 5821_CR67 publication-title: Infect Immun doi: 10.1128/IAI.00004-13 |
| SSID | ssj0060956 |
| Score | 2.364956 |
| Snippet | The mechanisms underlying the clinical outcome disparity during human infection with Giardia duodenalis are still unclear. In recent years, evidence has... Background The mechanisms underlying the clinical outcome disparity during human infection with Giardia duodenalis are still unclear. In recent years, evidence... BackgroundThe mechanisms underlying the clinical outcome disparity during human infection with Giardia duodenalis are still unclear. In recent years, evidence... BACKGROUND: The mechanisms underlying the clinical outcome disparity during human infection with Giardia duodenalis are still unclear. In recent years,... Abstract Background The mechanisms underlying the clinical outcome disparity during human infection with Giardia duodenalis are still unclear. In recent years,... |
| SourceID | doaj pubmedcentral proquest gale pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | 239 |
| SubjectTerms | Analysis Biological diversity Clinical isolates Clinical outcomes Deoxyribonucleic acid Diagnosis Diamonds Diet DNA DNA libraries Feces Feces - parasitology gastrointestinal system Gene sequencing Genetic aspects genetic distance Genetic diversity genetic heterogeneity Genetic variation Genotype Genotype & phenotype Giardia Giardia duodenalis Giardia lamblia Giardiasis Giardiasis - parasitology Gut Heterogeneity Human human diseases Human subjects Humans Infection Infections Investigations Lymphocytes Metabolic pathways Metagenomics Microbiome Microbiomes Microbiota Microorganisms Microscopy monophyly Mucosal Multilocus Sequence Typing Parasites Parasitic diseases Parasitological research Patient outcomes Phylogenetics Phylogeny Polymerase chain reaction Prebiotics Protozoa Sequencing statistical analysis Therapeutic targets therapeutics |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Li9RAEG5kQfAivo2u0orgQcJOp9_HUVxXDx7UhcVL08_dwE4iJvP_re5khgmiXoSc0hWS1POrUPkaoVcAMixjkdcuulXNuCY55ljdiIZ4FiK3rgzIfhZn5-zTBb842Oorz4RN9MCT4k40d1KnELziDbNCOxEboRLcgHGSaGEvhZq3a6amHJxZ1MTuFxklTgbI1BLa5ibPqqmG1GRRhgpb_-85-aAoLQcmDyrQ6R10e4aOeD098l10I3b30M3vffkwfh_ZNR6u-vFy2-FNHG0mX920HtuZdQT3CQPYwymCVfCmnQiYNhG3HS4b9Q14GsyKAeePs_hDW5wHh20PuSnzJD5A56fvv707q-cNFGovKBnrxKLSIq0SdVYISy0DsEbdSnsVFNdMMtuI4IPzELVBQvflAE8lHwC2iVzTHqKjru_iY4ShrYsWjmhdZICxLCRJq6yOlLIYHasQ2enT-JldPG9ycW1Kl6GEmWxgwAam2MCQCr3ZX_Nj4tb4q_TbbKa9ZObFLifAW8zsLeZf3lKhl9nIJjNfdHm05tJuh8F8_PrFrCWHTgP0Iyv0ehZKPbyDt_OfCqCJTJa1kDxeSEJo-uXyzpfMnBoGA3hOSaUAJFToxX45X5nH3brYb4uMzlBZkz_LUKhVElKwhJd6NLnnXjdUMkCaSlRILRx3obzlStdeFXJxsqKZtI8_-R_qfopuNSXoZE3UMToaf27jMwBxo3te4vUXwvJBvA priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Li9RAEG50RfAivje6SiuCBwk7nfQrJxnFdfXgQV0YvDT9yuyAk6ybmf9vVadn3CAu5DRdgaTr9VVP5StCXgPIsJxHUbroZiUXDUOf42UlK-Z5iMK61CD7VZ6e8S8LscgHbkNuq9zFxBSoQ-_xjPwY0qCGcg1i67uL3yVOjcJ_V_MIjZvkFlKXYfGlFvuCC7nU5O5DGS2PB4jXCornCjvWdMVKNklGibP_38h8JTVN2yav5KGTe-RuBpB0Pmr8PrkRuwfk9s8-HY8_JHZOh_N-s9x2dB03FilY1ytPbeYeoX1LAfLRNoJu6Ho10jCtI111NI3rG-jYnhUDxSNa-mmVTIiGbQ8RCtkSH5Gzk48_PpyWeYxC6WXNNmXLo25kO2trZ6W0teUA2Wo3a7wOWjRccVvJ4IPz4LtBQQ3mAFW1PgB4k5jZHpODru_iIaFQ3EULV7QuckBaFkKl1baJdc1jdLwgbLefxmeOcRx18cukWkNLM-rAgA5M0oFhBXm7v-diZNi4Vvo9qmkviezY6Yf-cmmys5lGONW0IXgtKm5l42SspG7BKLlgbS0K8gqVbJD_osMGm6XdDoP5_P2bmSsB9QbsjyrImyzU9vAO3ubvFWAnkDJrInk0kQQH9dPlnS2ZHCAG89ecC_Jyv4x3YtNbF_ttkmkQMDfs_zI1ZCwFgVjBSz0ZzXO_N7XigDe1LIieGO5k86Yr3eo8UYyzWY3UfeLp9c_-jNypkjupkukjcrC53MbnANI27kXyxD_qtjmI priority: 102 providerName: ProQuest |
| Title | A shotgun metagenomic analysis of the fecal microbiome in humans infected with Giardia duodenalis |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/37464386 https://www.proquest.com/docview/2838788678 https://www.proquest.com/docview/2839741691 https://www.proquest.com/docview/3153704075 https://pubmed.ncbi.nlm.nih.gov/PMC10354925 https://doaj.org/article/95b79fddc8524a69b6e268fa44451f35 |
| Volume | 16 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3di9NAEF_OOwRfxG_jnWUVwQeJdpP9yoNIT-48Cx5yZ6H4suxuNr3ANfGaFPS_d3aTlgueIhQK3UlL5mPnN9vJbxB6BSBDU-pYbJwZx5RlxMccjROeEEtzx7QJDbKn_GRGp3M230GbcUe9ApsbSzs_T2q2unz78-rXBwj49yHgJX_XwD4soChOfCeaTEgM1dAeZCbhRzl8odt_FTy3WnjaSDAeQx3PNg_R3Pgdg0QV-Pz_3LWvpa1hS-W1HHV8D93twSWedN5wH-246gG6_b0OR-cPkZ7g5qJuF-sKL12rPT3rsrRY97wkuC4wwEFcOLAbXpYdRdPS4bLCYZRfg7vWLZdjf3yLP5XBvXC-rmH38kyKj9Ds-Ojbx5O4H7EQW56SNi6okxkvxkVqNOc61RTgXGrGmZW5ZBkVVCc8t7mxENe5gPrMAOIqbA7Ajvus9xjtVnXlniIMhZ_T8HLaOAooTMM2qqXOXJpS5wyNENnoU9mef9yPwbhUoQ6RXHU2UGADFWygSITebK_50bFv_FP60JtpK-mZs8MH9Wqh-kBUGTMiK_LcSpZQzTPDXcJlAQ5LGSlSFqGX3sjKc2NUvvlmoddNoz6fn6mJYFCLgH5EhF73QkUN92B1_ywDaMLTaQ0kDwaSELx2uLzxJbXxfQWITwopAUZE6MV22V_pG-IqV6-DTObBdEb-LpNCNhOwSQu4qSede251kwoKWFTyCMmB4w6UN1ypyotAP07Gqaf1Y8_-44f30Z0kxJSIiTxAu-1q7Z4DimvNCN0SczFCe5PJ9HwK74dHp1_PRuFMZBTC9jeZnUVW |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLZGJwQviDuBAQaBeEDR6vgS5wGhDjZaNiY0NmnixdiO01WiyVhaIf4Uv5FjJymLEHub1Kf4JGrO_TjH30HoBSQZmjHHY-PMMGY8I97mWJyIhFiWO65NaJDdF-Mj9vGYH6-h391ZGN9W2fnE4Kjzyvo98k0IgxLKNfCtb09_xH5qlP-62o3QaNRi1_36CSVb_WbyHuT7Mkl2tg_fjeN2qkBsBSWLuGBOZqIYFtRoITTVDDIYaoaZlbnkGUuZTkRuc2NBlfMUShIDSUZhc8hlhHf08NwraJ1RSBUGaH1re__zQef7PXqb6I7mSLFZQ4RIoVxPfI-cTEhMeuEvTAn4NxacC4b9Rs1zkW_nJrrRpqx41OjYLbTmytvo6tcqbMjfQXqE65NqMV2WeO4W2oO-zmcW6xbtBFcFhiQTFw60Ac9nDfDT3OFZicOAwBo3DWEux35TGH-YBaXF-bICn-jxGe-io0th8T00KKvSPUAYykmn4ee0cQxyOw3OWUudOUqZc4ZFiHT8VLZFNffDNb6rUN1IoRoZKJCBCjJQJEKvV_ecNpgeF1JveTGtKD0ed7hQnU1Va94q4ybNijy3kidMi8wIlwhZgBkwTgrKI_TcC1l5xI3St_RM9bKu1eTLgRqlHCoc4E8aoVctUVHBO1jdnpAATniQrh7lRo8SXILtL3e6pFqXVKu_BhShZ6tlf6dvsytdtQw0mU_RM_J_GgoxMgXXn8JL3W_Uc8UbmjLIcKWIkOwpbo95_ZVydhJAzcmQerBA_vDi__4UXRsfftpTe5P93UfoehJMK42J3ECDxdnSPYYUcWGetHaJ0bfLdgV_ADYydtk |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+shotgun+metagenomic+analysis+of+the+fecal+microbiome+in+humans+infected+with+Giardia+duodenalis&rft.jtitle=Parasites+%26+vectors&rft.au=McGregor%2C+Brett+A&rft.au=Razmjou%2C+Elham&rft.au=Hooshyar%2C+Hossein&rft.au=Seeger%2C+Drew+R&rft.date=2023-07-18&rft.issn=1756-3305&rft.eissn=1756-3305&rft.volume=16&rft.issue=1+p.239-239&rft.spage=239&rft.epage=239&rft_id=info:doi/10.1186%2Fs13071-023-05821-1&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1756-3305&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1756-3305&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1756-3305&client=summon |